Six immune subtypes of cancer, including C1 (wound healing), C2 (IFN-γ dominant), C3 (inflammatory), C4 (lymphocyte depleted), C5 (immunologically quiet) and C6 (TGF-γ dominant), were identified to define immune response patterns impacting the prognosis28. This evidence concerns the gene IFNG and cancer.